Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination

J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.06.023. Epub 2021 Jun 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Neutralizing
  • COVID-19*
  • Humans
  • RNA, Messenger
  • SARS-CoV-2
  • Vaccination

Substances

  • Antibodies, Neutralizing
  • RNA, Messenger